Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Circulation. Cardiovascular Interventions|September 20, 2022
Impact of Serial Coronary Stenoses on Various Coronary Physiologic IndicesJung-Min Ahn, Takaharu Nakayoshi, Takehiro Hashikata, et al.
Journal of Interventional Cardiology|November 28, 2019
Hemodynamic and Lesion Characteristics Associated with Discordance between the Instantaneous Wave-Free Ratio and Fractional Flow ReserveHiroyuki Arashi, Natsuko Satomi, Issei Ishida, et al.
ESC Heart Failure|November 21, 2017
Persistent high blood urea nitrogen level is associated with increased risk of cardiovascular events in patients with acute heart failureKentaro Jujo, Yuichiro Minami, Shintaro Haruki, et al.
Therapeutic Drug Monitoring|January 7, 2009
Urinary lipocalin-type prostaglandin D synthase: a potential marker for early gentamicin-induced renal damage?Hirokazu Nakayama, Hirotoshi Echizen, Tomoko Gomi, et al.
Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology|January 14, 2020
Recurrent pericardial effusion with pericardial amyloid deposition: a case report and literature reviewHiroko Itagaki, Tomoko Yamamoto, Kenta Uto, et al.
Cardiovascular Intervention and Therapeutics|November 22, 2018
Evaluation of the cut-off value for the instantaneous wave-free ratio of patients with aortic valve stenosisHiroyuki Arashi, Junichi Yamaguchi, Tonre Ri, et al.
Scientific Reports|April 6, 2021
Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndromeJihaeng Im, Erisa Kawada-Watanabe, Junichi Yamaguchi, et al.
Heart and Vessels|January 27, 2011
Efficacy of paclitaxel-eluting stent implantation in hemodialysis patientsMichiaki Higashitani, Fumiaki Mori, Norihiro Yamada, et al.
American Heart Journal|February 3, 2020
Long-term clinical outcomes with use of an angiotensin-converting enzyme inhibitor early after heart transplantationHiroyuki Arashi, Takuma Sato, Jon Kobashigawa, et al.
JAMA Cardiology|August 13, 2025
Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical TrialJunichi Yamaguchi, Hiroyuki Arashi, Nobuhisa Hagiwara, et al.
Pageof 7